EasySep™人Pan-ILC富集试剂盒

免疫磁珠负选细胞富集试剂盒

产品号 #(选择产品)

产品号 #17975_C

免疫磁珠负选细胞富集试剂盒

产品优势

  • 操作简单、快捷,且无需分离柱
  • 获得的活细胞无标记
  • 利于快速流式分选ILC

产品组分包括

  • EasySep™ 人Pan-ILC富集试剂盒(产品号 #17975)
    • EasySep™人Pan-ILC2富集抗体混合物,0.5 mL
    • EasySep™ Dextran RapidSpheres™ 50100 磁珠,1 mL
  • RoboSep™ 人Pan-ILC富集试剂盒(产品号 #17975 RF)
    • EasySep™人Pan-ILC2富集抗体混合物,0.5 mL
    • EasySep™ Dextran RapidSpheres™ 50100 磁珠,1 mL
    • RoboSep™ 缓冲液(产品号 #20104)
    • RoboSep™过滤吸头(产品号 #20125)
New look, same high quality and support! You may notice that your instrument or reagent packaging looks slightly different from images displayed on the website, or from previous orders. We are updating our look but rest assured, the products themselves and how you should use them have not changed. Learn more

总览

EasySep™人Pan-ILC富集试剂盒通过免疫磁珠负选,从白细胞单采术样本中富集Group1、2和3 先天淋巴细胞(ILC1、2和3)。非目的细胞通过与抗非ILCs的抗体四聚体复合物及葡聚糖包被的磁珠(RapidSpheres™)结合而被去除。通过EasySep™磁极分离被标记的细胞,无需使用分离柱。富集的ILCs可被倾倒或吸取至一个新的试管中,非目标细胞仍保留在原管中。分选的细胞可被立即用于下游应用。

磁体兼容性
• “The Big Easy” EasySep™ Magnet (Catalog #18001) • Easy 50 EasySep™ Magnet (Catalog #18002) • EasyEights™ EasySep™ Magnet (Catalog #18103) • RoboSep™-S (Catalog #21000)
 
亚型
细胞分选试剂盒
 
细胞类型
先天性淋巴细胞
 
种属

 
样本来源
Leukapheresis,PBMC
 
筛选方法
Negative
 
应用
细胞分选
 
品牌
EasySep,RoboSep
 
研究领域
免疫
 

Data Figures

Typical EasySep™ Human Pan-ILC Enrichment Profile

Figure 1. Typical EasySep™ Human Pan-ILC Enrichment Profile

Starting with fresh leukapheresis samples, the total ILC content (Lin-CD45+CD127+) of the enriched fraction typically ranges from 17 - 85%. In the above example, the percentages of ILCs in the start and final enriched fractions are 0.09% and 45% (or 0.1% and 54% of CD45+ cells), respectively.

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
17975
Lot #
All
Language
English
Catalog #
17975RF
Lot #
All
Language
English
Document Type
Safety Data Sheet 1
Catalog #
17975
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Catalog #
17975
Lot #
All
Language
English
Document Type
Safety Data Sheet 1
Catalog #
17975RF
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Catalog #
17975RF
Lot #
All
Language
English
Document Type
Safety Data Sheet 3
Catalog #
17975RF
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Resources and Publications

Educational Materials (12)

Publications (1)

Endothelin-A Receptor Antagonist Alleviates Allergic Airway Inflammation via the Inhibition of ILC2 Function. X. Zhang et al. Frontiers in immunology 2022

Abstract

Allergic airway inflammation is a universal airway disease that is driven by hyperresponsiveness to inhaled allergens. Group 2 innate lymphoid cells (ILC2s) produce copious amounts of type 2 cytokines, which lead to allergic airway inflammation. Here, we discovered that both peripheral blood of human and mouse lung ILC2s express the endothelin-A receptor (ETAR), and the expression level of ETAR was dramatically induced upon interleukin-33 (IL-33) treatment. Subsequently, both preventive and therapeutic effects of BQ123, an ETAR antagonist, on allergic airway inflammation were observed, which were associated with decreased proliferation and type 2 cytokine productions by ILC2s. Furthermore, ILC2s from BQ123 treatment were found to be functionally impaired in response to an interleukin IL-33 challenged. And BQ123 treatment also affected the phosphorylation level of the extracellular signal-regulated kinase (ERK), as well as the level of GATA binding protein 3 (GATA3) in activated ILC2s. Interestingly, after BQ123 treatment, both mouse and human ILC2s in vitro exhibited decreased function and downregulation of ERK signaling and GATA3 stability. These observations imply that ETAR is an important regulator of ILC2 function and may be involved in ILC2-driven pulmonary inflammation. Therefore, blocking ETAR may be a promising therapeutic strategy for allergic airway inflammation.

更多信息

更多信息
Species Human
Magnet Compatibility • “The Big Easy” EasySep™ Magnet (Catalog #18001) • Easy 50 EasySep™ Magnet (Catalog #18002) • EasyEights™ EasySep™ Magnet (Catalog #18103) • RoboSep™-S (Catalog #21000)
Sample Source Leukapheresis, PBMC
Selection Method Negative
标记抗体
PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED. FOR ADDITIONAL INFORMATION ON QUALITY AT STEMCELL, REFER TO WWW.STEMCELL.COM/COMPLIANCE.
版权 © 2025 STEMCELL Technologies 技术有限公司。保留所有权利。